S2K

S2K (also known as S2K Bioscience) is a biotechnology company focused on the development of innovative therapeutics and diagnostic tools using proprietary aptamer technology. The company specializes in creating single-stranded DNA or RNA molecules that can bind to specific targets, such as viruses or cancer cells, with high affinity and specificity. S2K's platform aims to provide sensitive alternatives to traditional antibody-based therapies and diagnostics, potentially improving accuracy and efficacy in treating infectious diseases and oncology. Currently in the pre-clinical stage, the company is working to advance its lead candidates through early-stage development and validation.